Daniel Edward Heath

Daniel Edward Heath

Auto-generated profile, based on publicly available information

Daniel Edward Heath

Department of Biomedical Engineering The University of Melbourne Parkville Victoria Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
THTao Huang
Tao Huang
JHJames A. Holden
James A. Holden
DHDaniel E. Heath
Daniel E. Heath
NONeil O'Brien-Simpson
Neil O'Brien-Simpson
AOAndrea J. O'COnnor
Andrea J. O'COnnor
The overuse of antibiotics has induced the rapid development of antibiotic resistance in bacteria. As a result, antibiotic efficacy has become limited, and infection with multidrug-resistant bacteria is considered to be one of the largest global human health threats. Consequently, new, effective and safe antimicrobial agents need to be developed urgently. One promising candidate to address this requirement is selenium nanoparticles (Se NPs), which are made from the essential dietary trace element Se and have antimicrobial activity against Gram-positive bacteria. The size of nanomaterials can strongly affect their biophysical properties and functions; however, the effects of the size of Se NPs on their antibacterial efficacy has not been systematically investigated. Therefore, in this work, spherical Se NPs ranging from 43 to 205 nm in diameter were fabricated, and their mammalian cytotoxicity and antibacterial activity as a function of their size were systematically studied. The antibacterial activity of the Se NPs was shown to be strongly size dependent, with 81 nm Se NPs showing the maximal growth inhibition and killing effect of methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA). The Se NPs were shown to have multi-modal mechanisms of action that depended on their size, including depleting internal ATP, inducing ROS production, and disrupting membrane potential. All the Se NPs were non-toxic towards mammalian cells up to 25 μg mL−1. Furthermore, the MIC value for the 81 nm particles produced in this research is 16 ± 7 μg mL−1, significantly lower than previously reported MIC values for Se NPs. This data illustrates that Se NP size is a facile yet critical and previously underappreciated parameter that can be tailored for maximal antimicrobial efficacy. We have identified that using Se NPs with a size of 81 nm and concentration of 10 μg mL−1 shows promise as a safe and efficient way to kill S. aureus without damaging mammalian cells.

1 May 2021 in Chemical Engineering Journal
Verified
Journal Article
Closed access
Seungju KimSeungju Kim
Seungju Kim
CSColin A. Scholes
Colin A. Scholes
DHDaniel E. Heath
Daniel E. Heath
SKSandra Kentish
Sandra Kentish

1 April 2014 in Biomaterials
Verified
Journal Article
Open access
CNChee Ping Ng
Chee Ping Ng
ASAbdul Rahim Mohamed Sharif
Abdul Rahim Mohamed Sharif
DHDaniel E. Heath
Daniel E. Heath
JCJohn W. Chow
John W. Chow
CZClaire By. Zhang
Claire By. Zhang
LGLinda G. Griffith
Linda G. Griffith
Large-scale expansion of highly functional adult human mesenchymal stem cells (aMSCs) remains technologically challenging as aMSCs lose self renewal capacity and multipotency during traditional long-term culture and their quality/quantity declines with donor age and disease. Identification of culture conditions enabling prolonged expansion and rejuvenation would have dramatic impact in regenerative medicine. aMSC-derived decellularized extracellular matrix (ECM) has been shown to provide such microenvironment which promotes MSC self renewal and "stemness". Since previous studies have demonstrated superior proliferation and osteogenic potential of human fetal MSCs (fMSCs), we hypothesize that their ECM may promote expansion of clinically relevant aMSCs. We demonstrated that aMSCs were more proliferative (∼ 1.6 ×) on fMSC-derived ECM than aMSC-derived ECMs and traditional tissue culture wares (TCPS). These aMSCs were smaller and more uniform in size (median ± interquartile range: 15.5 ± 4.1 μm versus 17.2 ± 5.0 μm and 15.5 ± 4.1 μm for aMSC ECM and TCPS respectively), exhibited the necessary biomarker signatures, and stained positive for osteogenic, adipogenic and chondrogenic expressions; indications that they maintained multipotency during culture. Furthermore, fMSC ECM improved the proliferation (∼ 2.2 ×), size (19.6 ± 11.9 μm vs 30.2 ± 14.5 μm) and differentiation potential in late-passaged aMSCs compared to TCPS. In conclusion, we have established fMSC ECM as a promising cell culture platform for ex vivo expansion of aMSCs.


28 March 2019 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
DHDaniel E. Heath
Daniel E. Heath

1 March 2014 in Biomaterials
Verified
Journal Article
Closed access
SRShahrzad Rayatpisheh
Shahrzad Rayatpisheh
DHDaniel E. Heath
Daniel E. Heath
ASAmir Shakouri
Amir Shakouri
PRPim-On Rujitanaroj
Pim-On Rujitanaroj
Sing Yian ChewSing Yian Chew
Sing Yian Chew
MCMary B. Chan-Park
Mary B. Chan-Park